Patent 7375230 was granted and assigned to Kosan Biosciences on May, 2008 by the United States Patent and Trademark Office.
Migrastatin and a migrastatin analog can be produced by fermentation of Streptomyces platensis NRRL 18993 and used in pharmaceutical formulations to treat cancer and/or inhibit metastasis of cancer cells.